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Introduction: We assessed the usefulness of SARS-CoV-2 RT-PCR cycle thresholds
(Ct) values trends produced by the LHUB-ULB (a consolidated microbiology laboratory
located in Brussels, Belgium) for monitoring the epidemic’s dynamics at local and national
levels and for improving forecasting models.
Methods: SARS-CoV-2 RT-PCR Ct values produced from April 1, 2020, to May 15,
2021, were compared with national COVID-19 confirmed cases notifications according
to their geographical and time distribution. These Ct values were evaluated against both
a phase diagram predicting the number of COVID-19 patients requiring intensive care
and an age-structured model estimating COVID-19 prevalence in Belgium.
Results: Over 155,811 RT-PCR performed, 12,799 were positive and 7,910 Ct values
were available for analysis. The 14-day median Ct values were negatively correlated
with the 14-day mean daily positive tests with a lag of 17 days. In addition, the 14-day
mean daily positive tests in LHUB-ULB were strongly correlated with the 14-day mean
confirmed cases in the Brussels-Capital and in Belgium with coinciding start, peak, and
end of the different waves of the epidemic. Ct values decreased concurrently with the
forecasted phase-shifts of the diagram. Similarly, the evolution of 14-day median Ct
values was negatively correlated with daily estimated prevalence for all age-classes.
Conclusion: We provide preliminary evidence that trends of Ct values can help to both
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follow and predict the epidemic’s trajectory at local and national levels, underlining that
consolidated microbiology laboratories can act as epidemic sensors as they gather data
that are representative of the geographical area they serve.
Keywords: COVID-19, SARS-CoV-2, forecast, epidemic trend, cycle threshold (Ct) value
INTRODUCTION
The coronavirus disease 2019 (COVID-19) pandemic
dramatically highlighted the central position of diagnostic
testing, not only for the clinical management of infected
individuals but also for surveillance purposes (1). The use of
clinical microbiology laboratories (CMLs) data to survey the
presence of specific microorganisms in a given population
represents one of the most established public health surveillance
tools of infectious diseases. In a previous study, we proved
that influenza trends in Belgium may be estimated using
laboratory data provided by a CML serving the wider Brussels-
Capital Region area (2). Since the start of the COVID-19
pandemic, several authors have demonstrated that CMLs could
represent the first step toward a global set of sensor networks
for infectious diseases surveillance, where each one of the
CMLs can be seen as a real-time sensor in its area within an
interconnected, complex network (1, 3, 4). In this perspective,
CMLs have become a cornerstone in the fight against SARS-
CoV-2 infections due to their ability to process large amounts of
samples in large geographic areas while using highly specialised
diagnostic tests (1, 5).
By reporting to Sciensano, the Belgian national public health
research institute, the number of new positives among the tests
conducted each day, CMLs share the data needed to estimate
the effective reproduction number (Rt) (6, 7). However, the data
represent the growth rate of positive tests and not the incidence
of infection, which requires adjustments to account for changes
in testing capacity, delay between infection and test report date,
and conversion from prevalence to incidence. We previously
showed that SARS-CoV-2 RT-PCR cycle threshold (Ct) values
are different between populations, with lower Ct values — thus
higher viral loads — for outpatients, likely to be recently infected
and higher Ct values for inpatients (8). In a recent article, Hay et
al. used the SARS-CoV-2 RT-PCRCt values in amodel to forecast
epidemic’s trajectory (9). At the time of writing, RT-PCR assays
are not standardised and the Ct values obtained using various
PCR methods on various instruments in various laboratories
using various sampling methods cannot be easily aggregated by
surveillance systems. Sciensano recently encouraged laboratories
to report their results using a semi-quantitative approach where
a viral load below 103 RNA copies/mL is considered as “weak
positive” (10). Sciensano’s primary goal was to approach the
actual infectiousness of patients with persistent positive RT-
PCR. Therefore, the semi-quantitative dimension of positive test
results is not used by surveillance systems yet.
Besides the difficulty of making use of all the data provided
by CMLs in real time, public health authorities also face
the challenge of making decisions, as the constantly evolving
situation requires permanent adaptation (11). In this perspective,
various predictive models have been developed to support
policy makers (12–15). To improve and facilitate the decision-
making process, Hens et al. developed a phase portrait to
monitor the epidemic allowing a real-time assessment of whether
intervention measures are needed to keep hospital capacity
under control (16). Nevertheless, such supportive decision tools
are often designed at the national level instead of the hospital
level where, during the pandemic, hospital managers needed
support to forecast the cancellation and reintroduction of a
series of medical activities, such as the surgical care program,
or the number of COVID-related ICU beds (17). Thanks to
the huge amount of data they collect on a daily basis, CMLs
could also help the hospital structures they serve to anticipate the
evolution of the epidemic and forecast their hospitalisation and
medical activities.
The objectives of this study were: (1) to verify the accuracy
of using of SARS-CoV-2 PCR Ct values trends in a single CML
to monitor the dynamics of the epidemic; (2) to determine
the added-value of using these data as an additional advanced
information for scenario analysis, in relation to a phase diagram
and an age-structured compartmental model, both developed to
follow the path of the Belgian COVID-19 epidemic (14, 15).
METHODS
The “Laboratoire Hospitalier Universitaire de Bruxelles -
Universitair Laboratorium Brussel” (LHUB-ULB) is a merged
clinical laboratory serving five university hospitals located in
the Brussels-Capital region in Belgium (8). All the SARS-CoV-
2 PCR results produced between April 1, 2020, and May 15,
2021, by the LHUB-ULB were extracted anonymously from its
laboratory information system. The data collected were patients’
postal code, age, qualitative PCR results, Ct values, instruments
on which PCR were performed, and sampling dates. National
Belgian data were extracted from the “total number of tests
by date” and the “confirmed cases by date, province, age and
sex” public dataset available on the Sciensano website on May
27, 2021. These datasets contain the total number of tests, the
number of positive tests per day, and the confirmed number of
cases per day and province. All Ct values were considered at their
time of sampling regardless the days since symptoms onset or
deduplication. To analyse trends and minimise day-to-day and
holiday-related fluctuations, we computed mean daily positive
tests and cases, and median and mean Ct values from May 1,
2020 to May 15, 2021, using a backward sliding window of 14
days (hereafter referred as “14-day mean positive tests/cases” and
“14-day median/mean Ct values”).
To follow the trends of Ct values variation during the study
period, only the SARS-CoV-2 PCR results on nasopharyngeal
Frontiers in Medicine | www.frontiersin.org 2 November 2021 | Volume 8 | Article 743988
Yin et al. Ct Values Forecasting COVID-19 Trends
swabs (NPS) obtained using the m2000 RealTime SARS-CoV-2
assay (Abbott Molecular, USA) were considered, this assay being
the only one used by our laboratory during the entire period
of interest. As detection of both targeted genes (RdRp and N)
was performed using the same fluorophore, the Ct values of this
assay were observed up to 32 cycles and were not comparable
with Ct values of other RT-PCR assays. Ct values were plotted
against a standard calibration curve provided by the Belgian
NRC to obtain the semi-quantitative results recommended by
Sciensano (10). Accordingly, results with a Ct > 22.3 were
considered as “weak positive” (viral load < 103 RNA copies/mL).
Correlations between 14-day median/mean Ct values and daily
mean positive tests were calculated using Spearman’s rS rank
correlation coefficient. This correlation was performedwith shifts
of 0 to 30 days in the median and mean Ct values, to determine
the shift with the highest rS between the daily mean number of
positive tests and Ct values. To test their validity as a source for
COVID-19 surveillance, LHUB-UB’s data were also compared
with all COVID-19 confirmed case notifications according to
geographical coverage and time distribution.
We used phase diagrams depicting the evolution of COVID-
19 hospitalisations in Belgium to compare these trends with
the evolution of Ct values measures through time (16). These
diagrams were developed to predict the number of COVID-
19 patients requiring intensive care by considering the 7-day
mean new hospitalisations and the daily ratio of the past 14-day
new hospitalisations. For each combination, the total number of
hospitalisations is projected for a horizon of 14 days, from which
the number of patients requiring intensive care is predicted based
on the distribution of the time spent in an intensive care unit
(ICU). The hospital contingency plan in Belgium consists of five
different phases (phases 0, 1A and 1B, 2A and 2B), incrementing
COVID-19 related ICU beds capacities (18). Within this scheme,
the total number of patients in ICU moves from 2001 to 2821,
yielding a gradual decrease in non-COVID-19 ICU capacity (16).
The hospital and future COVID-related ICU load is thus depicted
from green to red: the green region can be considered a “safe
zone” in which the number of new hospitalisations is limited with
a decrease (growth < 1) or a limited increase (growth > 1) and
associated with a limited number of COVID-19 patients at ICU
(first part of Phase 0); the yellow region, a region of increased
vigilance (second part of Phase 0). The orange (Phases 1A and 1B)
and red (Phases 2A and 2B) regions are “high impact” and “no-
go” zones, in which non-COVID-19 care decreases substantially
and additional capacity for COVID-19 needs to be provided for.
A comparison between the evolution of 14-day median
Ct values by age classes and the daily estimated Belgian
COVID-19 prevalence for theses age classes has been performed
using a model of deterministic continuous age-structured
compartmental model (extended SEIR-type) integrating social
contact data and calibrated on hospitalisations and deaths
incidence data as well as serological studies (15). The prevalence
was estimated for the following age classes in years: 0–24,
25–44, 45–64, 65–74, and 75+ as the proportion of the
sum of the infected compartments (exposed, asymptomatic,
presymptomatic, symptomatic, and hospitalised individuals)
compared to the total size of the age class, with a 90% confidence
interval estimated by Bayesian analysis. This method aims to
provide a reliable comparison with the spreading of COVID-
19 in Belgium among age classes since the number of RT-PCR
positive tests are known to be biassed over time due to testing
policy changes (19).
Data from all sources were collected retrospectively and
anonymously before analysis from a routine surveillance
perspective without any additional intervention. Therefore,
ethical review and approval was not required for the study
on human participants in accordance with the local legislation
and institutional requirements. Written informed consent from
the participants’ legal guardian/next of kin was not required
to participate in this study in accordance with the national
legislation and the institutional requirements.
RESULTS
Ct Values vs. Epidemic Trends
From April 1, 2020, to May 15, 2021, a total of 155,049 SARS-
CoV-2 RT-PCR were performed in the LHUB-ULB and resulted
in 12,771 positive results of which 7,906 Cts were analysed. A
peak of LHUB-ULB 14-day mean daily positive tests was reached
during the Belgian second wave on October 28, 2020 (n = 153.6,
Figure 1). Beforehand, a lower peak was reached during the
summer on August 22, 2020 (n = 24.4). In both cases, these
peaks were preceded by a drastic decrease in the 14-day median
Ct values reaching local minima, respectively, 16 days before
(13.12 on October 12, 2020) and 12 days before (12.76 on August
10, 2020). Ct values were negatively correlated with the number
of LHUB-ULB positive tests, with a maximum reached for the
correlation between the 14-day median Ct values with a lag of 17
days and the 14-day mean positive tests (rS = −0.836), as well as
between the 14-day mean Ct values with a lag of 19 days and the
14-day mean positive tests (rS =−0.834).
CML Data vs. Local and National Data
During the same period, a total of 1,381,393 tests were performed
across the Brussels Region and 13,219,135 tests across the whole
of Belgian territory, of which, respectively, 142,562 and 1,131,719
tests were positive. Overall, LHUB-ULB performed, respectively,
8.96% (12,771/142,562) and 1.13% (12,771/1,131,719) of all
positive tests reported in the Brussels Region and at the national
level. Figure 2 shows the geographical distribution by postal
code of the confirmed COVID-19 cases notified by the LHUB-
ULB to Sciensano and the LHUB-ULB’s representativeness in
the COVID-19 notification (proportion of cases identified by the
national surveillance network thank to the reporting of LHUB-
ULB positive test results). Beside the Brussels Region, which
concentrated most of the tests produced by the LHUB-ULB,
its service area extended to several municipalities in Walloon
and Flemish Region with, for some of them, about 5% of all
notifications. Overall, the number of positive tests produced by
the LHUB-ULB showed a high correlation with the regional
and national trends of the incidence of COVID-19 notifications
with coinciding start, peak and end of the different waves of the
epidemic. The 14-day average number of positive tests in LHUB-
ULB were strongly correlated with the 14-day average number of
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FIGURE 1 | COVID-19 trends in a laboratory perspective: evolution of the 14-day median (solid red curve) and mean (dashed red curve) Ct values obtained from April
1, 2020, to May 15, 2021 (LHUB-ULB, Brussels Region, Belgium). Reddish areas surrounding the solid red curve indicate the 95% confidence interval (CI) associated
with median Ct values, and the thinner red dashed lines indicate the 95% CI associated with mean Ct values. The horizontal dashed line refers to the threshold value
of 22.3. Those curves are superimposed on the evolution of the number of COVID-19 positive PCR test results at the LHUB-ULB. As detailed in the text, median and
mean Ct values, as well as COVID-19 positive tests, were all computed using a backward 14-day sliding window. In the embedded box, we report the relationship
between (i) the Spearman correlation between daily estimates of median (solid curve) and mean (dashed curve) Ct values and the number of COVID-19 positive tests
(LHUB-ULB) and (ii) the time gap considered between the Ct measures and the number of positive tests. On top of the graph, we also report key dates of the
Belgian epidemic.
FIGURE 2 | Mapping by municipality of SARS-CoV-2 RT-PCR tests performed by the LHUB-ULB since March 8, 2020, and of the proportion of positive cases
detected by the LHUB-ULB compared to the overall number of positive cases detected in those areas. The Brussels Region is highlighted by a dark grey contour
and zoomed.
Frontiers in Medicine | www.frontiersin.org 4 November 2021 | Volume 8 | Article 743988
Yin et al. Ct Values Forecasting COVID-19 Trends
FIGURE 3 | Compared evolution of 14-day mean number of positive SARS-CoV-2 RT-PCR tests (LHUB-ULB) with Belgium (A) and Brussels (B) 14-day mean
COVID-19 cases.
positive tests in the Brussels Region (rS = 0.843) and in Belgium
(rS = 0.810) but also with the 14-day average confirmed cases in
the Brussels Region (rS = 0.832) and in the whole country (rS =
0.804) (Figure 3).
Ct Values Trends vs. Epidemic’s Dynamics
In Figure 4, the 14-days median estimates of daily Ct values are
plotted in a white to blue colour scale on the phase diagram
introduced above, showing how Ct values decrease when the
situation worsens (and vice versa) in trends making clockwise
movements. Figure 4A shows the downward trend of the end
of the first epidemic wave during which the growth in new
hospitalisations progressively decreased to reach below 0%, a
moment at which the number of new hospitalisations started to
decline: the Ct values, low at the peak, increase when the number
of new hospitalisations starts to decline. In Figure 4B, an upward
trend was observed, leading to a small summer wave. As soon
as both growth and hospitalisations passed from the green “safe
zone” to the yellow region of “increased vigilance,” the Ct values
started to decrease, concurrently crossing the threshold value of
22.3. The opposite effect was observed when the points fell in
the green region. The second wave is visualised in Figure 4C,
with a clear decrease and increase of the Ct values. Finally,
Figure 4D corresponds to the third wave, with again the same
pattern observed in the evolution of Ct values.
Ct Values Trends vs. Modelled Prevalence
by Age Group
In Figure 5, the median of daily Ct values for different age
groups are compared to the daily estimated prevalence of those
age groups. The overall behaviour of Ct values was almost
similar for all age classes and was negatively correlated to the
estimated prevalence.
DISCUSSION
Estimating the likely number of infected patients during
epidemics but also the dynamics of spreading in the population
is crucial to carry out adequate testing and infection control
measures. As large and accurate data providers, CMLs can
adequately support hospital capacity planning by providing
valuable real-time information about the incidence trends of the
pandemic. This was already established by a previous study on
influenza (2), but seems to be evenmore relevant in the context of
a more severe disease like COVID-19, where hospital capacities
are crucially challenged. Indeed, LHUB-ULB processed on its
own 8.95% of the SARS-CoV-2 testing in the Brussels-Capital
Region and was proved here to be representative not only of
the region but to a certain extent, the whole country due its
central geographic position in Belgium. A step further would
be to capitalise on the ability of these CMLs to rapidly detect
and communicate abnormal events such as sudden increase or
emergence of variants of concern without the delay resulting
from sending samples to central sequencing platforms. Thanks
to the expertise gained in such data integration, UK scientists
were able to rapidly share an early assessment of the variant
Alpha’s (lineage B.1.1.7) genomic characteristics and associated
clinical outcomes (20).
Complementarily, and providing an adequate standardisation
under appropriate management and regulatory structures,
“virtual” CMLs consolidation can also adequately support
ongoing COVID-19 surveillance by connecting some or all
the produced data to national public health surveillance
systems. In the frame of the COVID-19 pandemic, Sciensano
started to monitor on a daily basis the epidemiological
situation of SARS-CoV-2 in the country through multiple
surveillance systems including the “healthdata.be” platform
aggregating all information from all CMLs located in Belgium
(21–23). The added value of such a combined structure
was already demonstrated for monitoring viral infections by
the Infection Response Through Virus Genomics–ICONIC
consortium in London (24).
Beyond the variation of the infectiousness over time, our
results suggest that following the trend of SARS-CoV-2 RT-
PCR Ct values could predict the epidemic trends. Recently
infected patients are known to have higher viral load, thus higher
infectiousness (25). A decrease in Ct values, linked to an increase
of recently infected people is likely to favour spreading, and
goes hand in hand with an increase in the total number of
cases. On the contrary, inpatients are known to have higher
Ct values because of a longer evolution since the onset of the
disease. Thus, the overall increase of Ct values can be observed
before the decrease of hospitalisations at the decreasing phase
of an epidemic wave. By gathering enough comparable data
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FIGURE 4 | Phase diagram generated for different time periods: situation from March 1 to July 14, 2020 (A), situation from July 14 to September 1, 2020 (B), and
situation from September 1, 2020, to February 1, 2021 (C), situation from February 1 until May 15, 2021 (D). See the text for further detail on the principle of phase
diagrams. Dots of the phase diagram are coloured according to 14-day median Ct values (thus computed using a backward sliding window of 14 days, from May 1,
2020). Triangle symbols indicate the dates when Ct values crossed down the threshold value of 22.3.
using semi-quantitative results, our Ct values based surveillance
systems could approach in real time the average level of viral
load in the population, hence approach the current spreading of
the virus before the increase of cases becomes apparent, while
avoiding the recurrent problem of normalisation. Predicting the
shape and the size of the epidemic curve is not straightforward;
and many parameters may influence it such as seasonality,
infection control measures and population immunity level, to
cite a few. The evolution of 14-day median Ct values was also
tested against the daily estimated prevalence by age classes, and
Ct values were similarly negatively correlated for all age classes,
even we observed a shift by approximatively half a month for
the 75+ which might be due to intergenerational transmission.
However, a starting divergence was observed in May 2021,
with Ct values increasing for the oldest classes while remaining
low for the youngest one. This was related to a period of
resumption of activities in Belgium such as reopening of schools,
while older age-classes were progressively becoming protected
through the vaccination campaign. The prevalence projections
from the compartmental model followed the same trend. Hence,
Ct values divergence by age classes could be a good indicator of a
divergence in transmission in these age classes.
Following the trend of the Ct values might have helped
the decision makers as demonstrated with the integration of
the Ct values in a phase diagram predicting the number of
COVID-19 patients requiring intensive care at a national level.
For instance, in March 2021, after a long period of stagnation
in the epidemic, the Belgian government decided to reopen
close-contact professions and increased the number of people
authorised to gather outside, at a time when Ct values were
decreasing. This reopening was reversed a few weeks later due to
the increase of cases underlining the untimely decision. During
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FIGURE 5 | Ct evolution by age classes with comparison to the estimated prevalence: evolution of the daily 14-day median Ct values obtained using the Abbott
RealTime SARS-CoV-2 assay from April 1, 2020, to May 15, 2021 (LHUB-ULB, Brussels region, Belgium). Reddish areas surrounding solid red curves indicate the
95% confidence interval (CI) obtained by bootstrapping method associated with daily estimates of median Ct values. Those curves are superimposed on the daily
prevalence of COVID-19 infected people (proportion of infected vs. Belgian demographic data) as estimated by the age-structured extended SEIR-type mathematical
model. Solid grey curves indicate the 95% CI obtained by Bayesian analysis. Full data figure in Supplementary Material.
the summer 2020, the evolution of Ct values accurately followed
the dynamic of the epidemic with an increase accompanying
each decrease of the pressure on hospitals. But the shift between
the initial diagnosis, the admission, and the length of stay for
COVID-19 inpatients makes it harder to anticipate the trends
in hospitalisation between October 2020 and March 2021 when
the epidemic had no real break between peaks and the tension in
hospital beds remained stable. Only future evolution after a real
epidemic reflux could confirm the added value of following the
Ct values to anticipate the phase shifts.
At the hospital level, being able to foresee epidemic dynamics
could allow a greater ability to anticipate measures such as
pre-admission screenings, isolation, and postponement of non-
urgent interventions, triage, and upscaling of human resources.
In our study, each epidemic wave was preceded by a drastic
decrease of Ct values, the median crossing back the Ct = 22.3
value threshold (i.e. the proportion of “weak positive” tests went
below 50%), setting here an eventual easy-to-evaluate parameter
at the local level. This threshold value of 22.3 was clearly
crossed back concurrently with the passage of the number of
new hospitalisations vs. the new hospitalisations’ daily ratio
from the green “safe zone” to the yellow region of “increased
vigilance” in the phase diagram. Even if the setting described
here should likely be adjusted before being transposed to other
laboratories to take account of the specificity of their own patients
(ratios inpatients/outpatients and symptomatic/asymptomatic),
repeating this exercise with their own data could allow them to
set up their own alarm threshold. Likewise, local and national
surveillance systems should track the difference in the proportion
of strong vs. weak positive results to model the dynamics of the
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epidemic and thus to provide guidance for prevention measures
as suggested by Hay et al. (9).
A potential weakness of our data is that a limited part
of the LHUB-ULB activity relies on ambulatory patients at
the general practitioner level. Being able to reach this “non-
hospitalised” population would likely increase the sensitivity
of a surveillance system to weak signals when the epidemic
begins in the community before affecting hospitals. However,
the fact that overall behaviour of Ct values was almost similar
for all age classes and was negatively correlated to the estimated
prevalence in the compartment model indicates that our data
capture the whole Belgian population to a sufficient extend. One
could also argue that correlation between Ct value and actual
viral load depends on many factors, such as sampling method,
targeted genes, primers and probes, and possible mutations
in targeted genes (26). Due to the absence of standardisation
between SARS-CoV-2 RT-PCR assays, we only analysed Ct values
obtained using one RT-PCR assay performed on nasopharyngeal
swabs all along the studied period. We do believe that their
number is sufficient to neutralise the effect of measurement bias.
Furthermore, it has been discussed that some variants could
exhibit an average higher viral load (20, 27, 28) which could
directly impact observed trends in the overall evolution of Ct
values. Nevertheless, this potentially higher viral load is likely to
favour infectiousness and should not introduce a bias regarding
epidemic surveillance.
In conclusion, this study established a correlation between
the trends in the SARS-CoV-2 RT-PCR Ct values and the trends
of the COVID-19 incidence a few days later. Following the
dynamics of the average viral load could add a dimension in
the surveillance of respiratory infectious diseases. Moreover, it
underlines that the considerable amount of data daily collected
by CMLs can play a key role at both local level and beyond,
depending on the geographical area they serve. By gathering
comparable laboratory data approaching the average viral load
of respiratory viruses in the population, surveillance systems
might be able to better follow epidemic dynamics, establish
forecast models, capture weak signals, and thus anticipate
uncontrolled spreading.
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